Armata Cleared to Advance Phage Therapy AP-SA02 In...
Category : Clinical Trial Update 14 January 2026Armata Pharmaceuticals has received a positive End-of-Phase 2 (EOP2) written response from the US FD...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Johnson & Johnson Showcases New Phase 3 Neuropsych...
Category : Clinical Trial Update 14 January 2026Johnson & Johnson will present 11 new scientific abstracts across depression, schizophrenia, and...
Thryv Initiates Wave II Pivotal Study of THRV-1268...
Category : Clinical Trial Update 14 January 2026Thryv Therapeutics has initiated Wave II, a pivotal Phase 2/3 clinical study evaluating THRV-1268, i...
MRM Health receives US FDA IND clearance to initia...
Category : Clinical Trial Update 12 January 2026"MRM Health NV, a clinical-stage biopharmaceutical company pioneering microbiome-based therapeu...
NRG Therapeutics doses its first-in-human phase 1...
Category : Clinical Trial Update 12 January 2026"NRG Therapeutics Ltd, a clinical stage neuroscience company targeting a novel mechanism to rec...
Latest Newsletter Post
-
Thryv Initiates Wave II Pivotal Stu..
14 January 2026
-
Johnson & Johnson Showcases New Pha..
14 January 2026
-
Armata Cleared to Advance Phage The..
14 January 2026
-
Clover Initiates Phase 2 Clinical T..
12 January 2026
-
NRG Therapeutics doses its first-in..
12 January 2026
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com